RANI 8-K 2026-11-09

Rani Therapeutics Holdings, Inc. (RANI) 8-K dated 2026-11-09 — accession 0001193125-26-453804.

Rani Therapeutics Holdings, Inc. (RANI) is a biotechnology company listed on US.

RANI: Rani Therapeutics Reports Third Quarter 2026 Financial Results; Provide…

This 8-K covers: Results of operations (Item 2.02), Exhibits (Item 9.01). SEC EDGAR holds the official filing and its exhibits.

Latest reported RANI revenue for 2025-12-31 was $1.6M. Net income was -$29.7M. Revenue was up 58.9% from 2024-12-31 to 2025-12-31. RANI currently screens at market cap $41.5M.

Not investment advice. The RANI SEC hub lists recent forms. The stock page is the research view.